latest news releases from the newsroom
Tikvah Therapeutics, Inc.
Tikvah Therapeutics Selected for 'Main-Stage' Presentation At the Ninth Annual Southeastern BIO Investor Forum
ATLANTA, Nov. 1, 2007 (PRIME NEWSWIRE) -- Tikvah Therapeutics, Inc., an Atlanta, GA-based biopharmaceutical company focused on new treatment options to better manage central nervous system diseases, announced today that it has been chosen as one of only 12 companies selected in the competition for a "main-stage" presentation at the Ninth Annual Southeastern BIO Investor Forum (SEBIO) to be held November 7-8, 2007, in Pinehurst, N.C. Dr. Harold H. Shlevin, president and chief executive officer of Tikvah Therapeutics, Inc., will present a corporate overview on Thursday, November 8, 2007, at 11:15 am EST.
Norsk Hydro: Executive Vice President Purchases Shares
OSLO, Norway, Nov. 1, 2007 (PRIME NEWSWIRE) -- Executive Vice President and member of Norsk Hydro ASA's corporate management board Anne Harris, has on November 1, 2007 purchased 6,000 shares in Hydro at NOK 78.80 per share. New holding is 6,136 shares. Any closely related parties are included in the transaction and holding.
Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals to Present At Acumen BioFin 9th Annual Healthcare Conference
NORTHVALE, N.J., Nov. 1, 2007 (PRIME NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (AMEX:ELI), will be presenting at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference to be held on November 5-7, 2007 at the New York Palace Hotel. The company's chairman and CEO, Bernard Berk, is scheduled to present an overview of the company and its clinical programs Wednesday, November 7th at 10:50 AM EDT. For more information on this event please visit: http://www.rodmanandrenshaw.com/conferences.